Ana Xavier, M.D., associate professor in the Division of Pediatric Hematology/Oncology, was a panel member in the development of the National Comprehensive Cancer Network (NCCN) Guidelines and Evidence Blocks for Pediatric Hodgkin Lymphoma.

Dr. Xavier assisted with developing the NCCN Evidence Blocks for Pediatric Hodgkin Lymphoma. NCCN Evidence Blocks are created to help providers and patients make informed decisions when selecting systemic therapies.